Understanding Wegovy vs Mounjaro Side Effects for UK Buyers
Wegovy Side Effects vs Mounjaro: Key Differences for UK Patients
When comparing Wegovy side effects vs Mounjaro, the most significant difference lies in their mechanisms of action and resulting side effect profiles. Wegovy (semaglutide) acts solely on GLP-1 receptors, typically causing gastrointestinal side effects in 20-30% of patients during initial dose escalation. Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors, which may result in different side effect patterns and potentially different tolerance levels between individuals.
The most commonly reported side effects for both medications include nausea, vomiting, diarrhoea, and constipation, though individual experiences vary significantly. Wegovy's side effect profile is well-documented through the STEP clinical trial programme, whilst Mounjaro's effects were studied in the SURMOUNT trials. Both prescription-only medicines require careful dose escalation to minimise side effects, and our prescribers at EverydayMeds provide detailed guidance on managing any initial discomfort during treatment initiation.
UK Pricing and Value: Wegovy Side Effects vs Mounjaro Costs
Understanding the cost implications of Wegovy side effects vs Mounjaro is crucial for UK patients planning their weight management journey. Wegovy is available through EverydayMeds from £79.99 for the 0.25mg starter dose (using code FIRST40), progressing to £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle combines the first two doses (0.25mg and 0.5mg) for £169.99, providing eight weeks of treatment during the critical initial period.
For patients concerned about side effects during dose escalation, our Gentle Start Trio bundle (£269.99) includes two 0.25mg pens and one 0.5mg pen, allowing extended time at the lowest dose. Both Wegovy and Mounjaro are available through our clinical assessment process, with returning customers using code DOSE25 at checkout. The pricing reflects the comprehensive service including prescriber consultation, genuine Novo Nordisk Wegovy, and temperature-controlled delivery across the UK.
Clinical Evidence: Wegovy Side Effects vs Mounjaro in Trials
Clinical trials comparing Wegovy side effects vs Mounjaro provide valuable insights for UK patients considering either treatment. The STEP trials (Wilding et al., NEJM, 2021) demonstrated that Wegovy patients experienced predominantly gastrointestinal side effects, with nausea being the most common adverse event, typically resolving within 4-8 weeks of dose stabilisation.
Mounjaro's SURMOUNT trial data suggests a similar side effect profile, though the dual GIP/GLP-1 mechanism may influence individual tolerance patterns differently. Both medications showed that side effects were generally mild to moderate and decreased over time as patients adapted to treatment alongside a reduced-calorie diet and increased physical activity.
How Wegovy Works: Understanding Side Effects vs Mounjaro's Mechanism
Wegovy's mechanism as a GLP-1 receptor agonist explains many of its side effects compared to Mounjaro's dual-pathway approach. Wegovy mimics the natural incretin hormone GLP-1, which slows gastric emptying and reduces appetite through brain appetite centres. This gastric slowing effect directly contributes to the nausea and digestive side effects experienced during initial treatment. The medication promotes feelings of fullness after smaller meals and may reduce food cravings, with side effects typically diminishing as the body adapts to this new satiety signalling. Understanding this mechanism helps patients recognise that initial side effects often indicate the medication is working as intended to modify appetite and eating patterns.
Ordering Process: Accessing Wegovy vs Mounjaro Side Effect Information
Our streamlined ordering process ensures you receive comprehensive information about Wegovy side effects vs Mounjaro before starting treatment. The 3-minute clinical assessment covers your medical history, current medications, and any concerns about potential side effects with either treatment option. Following assessment completion, our prescribers conduct a thorough review within 3 working days (or 24 hours with express service), providing personalised guidance on managing side effects during dose escalation. Once approved, we dispatch your medication via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements that preserve medication efficacy. This careful handling process ensures you receive genuine, properly-stored medication ready for safe use.
Storage and Practical Considerations: Wegovy vs Mounjaro Side Effect Management
Storage differences between Wegovy and Mounjaro may influence your choice when considering side effects and practical usage. Wegovy offers superior storage flexibility with 6 weeks room temperature tolerance (below 30°C) compared to Mounjaro's 21-day limit, reducing stress about medication storage during travel or daily use. The FlexTouch pen design allows easy dose administration, with clear dose escalation from 0.25mg through to 2.4mg maintenance therapy. Proper storage maintains medication stability and effectiveness, potentially reducing the risk of side effects caused by degraded medication. The mandatory dose escalation schedule helps minimise side effects by allowing your body to gradually adapt to increasing semaglutide levels over 16 weeks.
Side Effect Management Strategies: Wegovy vs Mounjaro for UK Patients
Managing Wegovy side effects vs Mounjaro requires understanding that both medications affect gastrointestinal function differently due to their distinct mechanisms. Wegovy patients often benefit from eating smaller, more frequent meals and avoiding high-fat foods during the initial weeks of treatment. The single GLP-1 pathway targeting may result in more predictable side effect patterns compared to Mounjaro's dual-receptor approach.
UK patients accessing either medication through EverydayMeds receive detailed side effect management guidance from our clinical team. This includes dietary recommendations, timing strategies for dose administration, and clear instructions on when to contact healthcare providers about concerning symptoms. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which medication's side effect profile aligns better with your lifestyle and medical history.
Complete Your Wegovy vs Mounjaro Assessment Today
Take the next step in your weight management journey by completing our clinical assessment to determine whether Wegovy or Mounjaro is appropriate for your needs. New customers can use code FIRST40 at checkout, whilst returning patients apply code DOSE25 to access our competitive pricing from £79.99. Our GPhC-registered pharmacy (#9012878) ensures you receive expert clinical oversight throughout your treatment journey, with comprehensive side effect monitoring and support. The assessment takes just 3 minutes to complete, followed by thorough prescriber review and next-day delivery of your chosen medication. Start your assessment today to access genuine, MHRA-approved weight management treatment with full clinical support across the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
